Day: June 12, 2020

CALGARY, Alberta, June 12, 2020 (GLOBE NEWSWIRE) — ARROW Exploration Corp. (“Arrow” or the “Company”) (TSXV: AXL) announces an update to its proposed non-brokered private placement (the “Private Placement”) of 13,000,000 common shares of the Company at a price of CAD$0.025 per share for gross proceeds of CAD$325,000, as well as the proposed grant of options and strategic review.As previously announced by the Company on May 23rd, 2020, the proposed Private Placement will be subscribed for by certain consultants and insiders of the Company in an amount of CAD$100,000 each in the case of insiders and CAD$25,000 in the case of the consultant. The Company has agreed to provide loans equivalent to their total subscription amount to each of the subscribers pursuant to promissory notes secured by the shares issued in the Private Placement.The...

WEST PALM BEACH, Fla., June 12, 2020 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that has transitioned its core business from diagnostics to rural hospital ownership over the past three years, announces that on June 10th it has entered into an agreement with TPT Global Tech, Inc. (OTC: TPTW), a CA based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) into a public company (target) after TPT completes a merger of its wholly owned subsidiary, InnovaQor, Inc. with this target.The parties anticipate the steps as defined in the agreement...

STOCKHOLM SWEDEN – June 12, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company Aprea Therapeutics has released results from a Phase 1b/2 clinical trial evaluating APR-246 (eprenetapopt) with azacitidine for the treatment of TP53 mutant myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The overall response rate (ORR) of 28 evaluable MDS patients reached 75%, with a 57% complete remission (CR) rate. With a median duration of follow-up of 9.7 months, the median overall survival (OS) for all enrolled patients, as well as for the MDS patients, was 12.1 months.All enrolled patients in the Phase 1b/2 study were to receive APR-246 as a 4,500 mg fixed dose IV daily for 4 days and azacitidine over 7 days in 28-day cycles. The primary endpoint of the trial is CR rate. The clinical...

STOCKHOLM, SVERIGE 12 juni 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Aprea Therapeutics har presenterat resultat från en Fas 1b/2-studie av APR-246 (eprenetapopt) i kombination med azacitidin för behandling av TP53-muterat myelodysplastiskt syndrom (MDS) och akut myeloisk leukemi (AML). Den totala responsen (ORR) hos 28 evaluerbara MDS-patienter nådde 75%, med en komplett respons (CR) om 57%. Efter en medianuppföljningstid på 9,7 månader uppgick total överlevnad (OS) för samtliga rekryterade patienter, liksom för MDS-patienterna, till 12,1 månader i median.  Samtliga rekryterade patienter i fas 1b/2-studien erhöll APR-246 som en 4 500 mg intravenös dos dagligen i fyra dagar och azacitidin under sju dagar i 28-dagars cykler. Studiens primära effektparameter är komplett respons (CR). Den...

Pixium Vision lance une augmentation de capitalavec maintien du droit préférentiel de souscriptiond’un montant maximum de 7,8 M€ pourl’étude pivot du Système PrimaExcellents résultats à 18 mois de l’étude de faisabilité en France, ayant démontré une amélioration importante de l’acuité visuelleDémarrage de l’étude prévu fin 2020 ou début 2021Parité de souscription : 15 actions nouvelles pour 26 actions existantesPrix de souscription : 0,50 € par action nouvelle, soit une décote faciale de 32,20%Période de négociation du Droit Préférentiel de Souscription du 16 au 29 juin 2020 inclusPériode de souscription du 18 juin au 1er juillet 2020 inclusOpération garantie à hauteur de 75% par des engagements de souscription de Sofinnova Partners et de Bpifrance Participations à hauteur de 2,6 M€ et par des engagements de garantie d’investisseurs qualifiés...

LAS VEGAS, June 12, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Golden Matrix Group Inc. (OTC: GMGI), a technology-driven company that designs and develops social gaming platforms, systems and gaming content, today announced that for the first fiscal quarter ended April 30, 2020, the company recorded net income of $229,739 on revenues of $734,764. This compares with a net income of $279,323 on revenues of $737,169 in like year-ago quarter. Net income reported in the first quarter was impacted adversely, by a non-cash amortization expense of $259,560. The company’s operating profit for the quarter – excluding derivative expense – was $520,795.Shareholder equity of $3,035,284 as of April 30, 2020 represents an increase of 23% on the previous quarter and 418% on the comparable quarter in the previous fiscal year. Cash...

This Initial Production Run is Expected to Yield Approximately 8,500 Blister Packs – Concentration of Cannabigerol (“CBG”) has Been Increased to 15mg / Each Piece of Chewing GumNEW YORK, NY, June 12, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences Company, with a proprietary line of functional “supplement” chewing gums (versions: infused with CBD, CBG, Vitamin C & Zinc) and edibles product(s) as well as two ongoing Biotechnology initiatives, today announced that it has completed payment for the entirety of its initial production run of its 2ndCannabigerol (“CBG”) infused version of Tauri-Gum™ (Black Currant Flavor).  This initial production is expected to yield approximately 8,500 Blister Packs (850 Retail Boxes)...

RICHMOND, Va., June 12, 2020 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO) today announced an amendment to its existing credit agreement that provides long-term covenant relief and added flexibility to execute its strategic plan. The amendment changes the methodology for calculating the company’s leverage ratio by using a net first lien leverage ratio (net secured debt leverage ratio) instead of a total net debt leverage ratio.  The new ratio excludes unsecured debt, which was approximately $600 million as of March 31, 2020, from leverage ratio calculations through the expiration of the agreement in 2024.Under the amended agreement, the maximum leverage ratio for the remainder of 2020 is 4.25x.  Pro forma for the G4S acquisition (assuming completion), the leverage ratio is 2.6x based on the trailing 12 months of Adjusted EBITDA...

COLUMBUS, Ohio, June 12, 2020 (GLOBE NEWSWIRE) — Pride may look a bit different this year…but with a little help (and magic) from local Columbus, Ohio Drag Queen Nina West, you’ll be ready to celebrate virtually all month long in Lane Bryant’s newest Pride collection, available now in all open Lane Bryant locations and on LaneBryant.com.Throughout Pride month, Lane Bryant will empower everyone to create their lane their own way by celebrating hope, inclusivity and love through a digital campaign starring West. Along with a few Lane Bryant associates, West encourages viewers to share how they “Say it with Love” during Pride with a dedicated video that dropped on Lane Bryant’s digital media channels today.Along with the video, Lane Bryant and West teamed up on an exclusive co-designed Nina West tee shirt that will be available in open...